Breaking

TECHCRUNCH Google gives in to users’ complaints over AI-powered ‘Ask Photos’ search feature Neutral CNBC BUSINESS FDA approves leucovorin as first drug for rare genetic disorder, after touting it as auti… Bullish THE DAILY CALLER Europe Leaving America In Dust After Years Of Being Beholden To China Bearish THE DAILY CALLER Editor Daily Rundown: Trump Warns GOP Senators Over Save America Act Strong Bearish CBS NEWS Iran vows to keep fighting as tensions ramp up over Strait of Hormuz Bearish NEW YORK TIMES BUSINESS What to Know About the Rising Price of Oil and Its Effects on Airline Ticket Prices Neutral FREIGHTWAVES MATS Is Three Weeks Away – Here Is Why Small Carriers Can’t Afford to Skip It Neutral CNBC BUSINESS Boaz Weinstein warns of private credit’s 'financial alchemy,' says problems are multiplyi… Strong Bearish MARKET WATCH Bill Ackman tries IPO market again with fund-management share giveaway Neutral CBS NEWS 1,300-pound NASA satellite set to crash down to Earth today Strong Bearish TECHCRUNCH Legora reaches $5.55 billion valuation as AI legaltech boom endures Strong Bullish MARKET WATCH A crucial safety net for energy and the world economy is missing as Iran conflict deepens Strong Bearish PIT & QUARRY ConExpo-Con/Agg attendance totals are in Neutral BUSINESS INSIDER I worked a corporate job for 8.5 years. I quit over a text message. Neutral CNBC TOP STORIES India's restaurants are under threat from the LPG supply crunch caused by the Iran war Strong Bearish WSJ ECONOMY For Europe’s Central Banks, the Energy Spike Isn’t a Straight Rerun of 2022 Neutral COINTELEGRAPH Trust Wallet adds real-time scam address checks for crypto users Bearish CBS NEWS What to know about bankruptcy waiting periods before filing this March Strong Bearish ABC NEWS US homes sales bounced back in February as homebuyers seized on easing mortgage rates Bullish MOTOR1 New Alpine A110 Staying Electric, But There's A Gas Backup Plan Neutral TECHCRUNCH Google gives in to users’ complaints over AI-powered ‘Ask Photos’ search feature Neutral CNBC BUSINESS FDA approves leucovorin as first drug for rare genetic disorder, after touting it as auti… Bullish THE DAILY CALLER Europe Leaving America In Dust After Years Of Being Beholden To China Bearish THE DAILY CALLER Editor Daily Rundown: Trump Warns GOP Senators Over Save America Act Strong Bearish CBS NEWS Iran vows to keep fighting as tensions ramp up over Strait of Hormuz Bearish NEW YORK TIMES BUSINESS What to Know About the Rising Price of Oil and Its Effects on Airline Ticket Prices Neutral FREIGHTWAVES MATS Is Three Weeks Away – Here Is Why Small Carriers Can’t Afford to Skip It Neutral CNBC BUSINESS Boaz Weinstein warns of private credit’s 'financial alchemy,' says problems are multiplyi… Strong Bearish MARKET WATCH Bill Ackman tries IPO market again with fund-management share giveaway Neutral CBS NEWS 1,300-pound NASA satellite set to crash down to Earth today Strong Bearish TECHCRUNCH Legora reaches $5.55 billion valuation as AI legaltech boom endures Strong Bullish MARKET WATCH A crucial safety net for energy and the world economy is missing as Iran conflict deepens Strong Bearish PIT & QUARRY ConExpo-Con/Agg attendance totals are in Neutral BUSINESS INSIDER I worked a corporate job for 8.5 years. I quit over a text message. Neutral CNBC TOP STORIES India's restaurants are under threat from the LPG supply crunch caused by the Iran war Strong Bearish WSJ ECONOMY For Europe’s Central Banks, the Energy Spike Isn’t a Straight Rerun of 2022 Neutral COINTELEGRAPH Trust Wallet adds real-time scam address checks for crypto users Bearish CBS NEWS What to know about bankruptcy waiting periods before filing this March Strong Bearish ABC NEWS US homes sales bounced back in February as homebuyers seized on easing mortgage rates Bullish MOTOR1 New Alpine A110 Staying Electric, But There's A Gas Backup Plan Neutral

AI-Powered Market News

Tuesday, March 10, 2026

Pulse

01 Iran Escalation Defies Trump's "Very Soon" Prediction as Markets Brace … PESSIMISTIC 02 Saudi Aramco Warns of "Catastrophic" Oil Market Consequences if Strait … PESSIMISTIC 03 Bitcoin's Quantum Defense Upgrade Falls Short as Crypto Theft Accelerat… PESSIMISTIC 04 Thailand Freezes 10,000 Crypto Accounts as Regulators Tighten AML Screw… PESSIMISTIC

All Stories →

Pessimistic Menu

FDA approves leucovorin as first drug for rare genetic disorder, after touting it as autism treatment

CNBC Business March 10, 2026 · 2:55 pm Read Original

Bullish 50.0

−100 Bearish 0 +100 Bullish

FDA approves leucovorin as first drug for rare genetic disorder, after touting it as autism treatment

The move comes months after the Trump administration touted leucovorin as a potential therapy for a broader group of patients with autism symptoms.

Read Read Source

Account Login for Pulse AI

Snap Export

Pulse analysis not available yet. Click "Get Pulse" above.

Generated by Pulse AI, Glideslope's proprietary engine for interpreting market sentiment and economic signals. For informational purposes only — not financial advice.

Source CNBC Business

Published Mar 10, 2026 · 2:55 pm

Article ID pec3sso

Original URL Open source

Bullish 50.0

−100Neutral+100

Fraywire, Breaking Metrics, and Glideslope AI are designed for informational purposes only. The content provided across these platforms—including, but not limited to, stock and crypto watchlists, price tracking, trade tracking, sentiment analysis, and news articles—should not be construed as financial advice or research reports. Users are encouraged to conduct their own research and consult with qualified financial professionals before making any investment decisions. While we strive to ensure the accuracy, completeness, and reliability of the information provided, Fraywire, Breaking Metrics, and Glideslope AI make no guarantees or warranties regarding the content's validity. By using these platforms, you acknowledge and agree that you are solely responsible for your own investment decisions and actions. Fraywire, Breaking Metrics, and Glideslope AI shall not be held liable for any losses or damages resulting from the use of the information provided.

Get Connected

Fraywire & Glideslope AI are Breaking Metrics productions.
Contact the developer at roy@fraywire.com

○ Subscribe
○ Fraywire+
○ Glideslope AI
○ urIssue

○ RMAHD

● MACRO ANALYST

Fraywire+

Unlock the AI Macro Analyst to drill down into the data, explore hidden risks, and query the entire market briefing in real-time.

LOG IN / SUBSCRIBE